Seeks to further amend notification No. 16/2017-Customs dated 20th April, 2017, which provides exemption to specified medicines under certain Patient Assistance Programmes (PAPs) run by pharmaceutical companies - 41/2020 - Customs -Tariff

GOVERNMENT OF INDIA MINISTRY OF FINANCE (DEPARTMENT OF REVENUE) Notification No. 41/2020-Customs New Delhi, the 29th October, 2020 G.S.R. 683 (E). - In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act,1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do, hereby makes the following further amendments in the notification of the Government of India, in the Ministry of Finance (Department of Revenue), No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R.394 (E), dated the 20th April, 2017 , namely:- In the said notification, in the Table, for the entries in column (3) and column (4) at the serial numbers given in column (1) of the Table below, the corresponding entries at column (2) and column (3) of the Table below shall be substituted, namely:- Table (1) (2) (3) 17. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited 18. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited 19. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited 20. Win for Patients- Cancer Care/ Umaang Sandoz India Private Limited 21. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited 22. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited 43. Sutent Patient Assistance Programme - STAR Pfizer Products India Private Limited 44. Crizalk Patient Assistance Programme - STAR Pfizer Products India Private Limited 45. Inlyta Patient Assistance Programme - STAR Pfizer Products India Private Limited 46. Palbace Patient Assistance Programme - PRERNA Pfizer Products India Private Limited 47. Enbrel Patient Assistance Programme Pfizer Limited 48. Xeljanz Patient Assistance Programme Pfizer Limited 49. Genotropin Patient Assistance Programme Pfizer Products India Private Limited 50. Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Patient Assistance Programme Pfizer Products India Private Limited 52. Campto Patient Assistance Programme Pfizer Products India Private Limited . [F. No. 332/24/2010-TRU (Pt.III)] (Gaurav Singh) Deputy Secretary to the Government of India Note: The principal notification No. 16/2017-Customs, dated the 20th April, 2017 was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R.394 (E), dated the 20th April, 2017 , and was last amended by notification No. 83/2017-Customs, dated the 31st October, 2017 published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R. 1356 (E), dated the 31 st October, 2017.